205 related articles for article (PubMed ID: 33446896)
1. CD117/c-kit defines a prostate CSC-like subpopulation driving progression and TKI resistance.
Harris KS; Shi L; Foster BM; Mobley ME; Elliott PL; Song CJ; Watabe K; Langefeld CD; Kerr BA
Sci Rep; 2021 Jan; 11(1):1465. PubMed ID: 33446896
[TBL] [Abstract][Full Text] [Related]
2. A juxtacrine/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancer.
Mazzoldi EL; Pavan S; Pilotto G; Leone K; Pagotto A; Frezzini S; Nicoletto MO; Amadori A; Pastò A
Cell Death Dis; 2019 May; 10(6):412. PubMed ID: 31138788
[TBL] [Abstract][Full Text] [Related]
3. Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease.
Hoogland AM; Verhoef EI; Roobol MJ; Schröder FH; Wildhagen MF; van der Kwast TH; Jenster G; van Leenders GJ
Prostate; 2014 May; 74(5):488-96. PubMed ID: 24375374
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z
Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of endothelial cell marker CD34 and mast cell marker CD117 in prostate adenocarcinoma.
Foroozan M; Roudi R; Abolhasani M; Gheytanchi E; Mehrazma M
Pathol Res Pract; 2017 Jun; 213(6):612-618. PubMed ID: 28552539
[TBL] [Abstract][Full Text] [Related]
6. CD117⁺ cells in the circulation are predictive of advanced prostate cancer.
Kerr BA; Miocinovic R; Smith AK; West XZ; Watts KE; Alzayed AW; Klink JC; Mir MC; Sturey T; Hansel DE; Heston WD; Stephenson AJ; Klein EA; Byzova TV
Oncotarget; 2015 Jan; 6(3):1889-97. PubMed ID: 25595903
[TBL] [Abstract][Full Text] [Related]
7. DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor receptor and ZEB1.
Yun EJ; Baek ST; Xie D; Tseng SF; Dobin T; Hernandez E; Zhou J; Zhang L; Yang J; Sun H; Xiao G; He D; Kittler R; Hsieh JT
Oncogene; 2015 May; 34(21):2741-52. PubMed ID: 25043300
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
9. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD133 and CD117 in 64 Serous Ovarian Cancer Cases.
Stemberger-Papić S; Vrdoljak-Mozetic D; Ostojić DV; Rubesa-Mihaljević R; Krigtofić I; Brncić-Fisher A; Kragević M; Eminović S
Coll Antropol; 2015 Sep; 39(3):745-53. PubMed ID: 26898076
[TBL] [Abstract][Full Text] [Related]
12. CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance.
Foster BM; Zaidi D; Young TR; Mobley ME; Kerr BA
Biomedicines; 2018 Mar; 6(1):. PubMed ID: 29518044
[TBL] [Abstract][Full Text] [Related]
13. Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop.
Levina V; Marrangoni A; Wang T; Parikh S; Su Y; Herberman R; Lokshin A; Gorelik E
Cancer Res; 2010 Jan; 70(1):338-46. PubMed ID: 20028869
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines.
Ma Y; Liang D; Liu J; Axcrona K; Kvalheim G; Giercksky KE; Nesland JM; Suo Z
Tumour Biol; 2012 Aug; 33(4):967-78. PubMed ID: 22252524
[TBL] [Abstract][Full Text] [Related]
15. [The diagnostic and predictive role of kit (CD117)].
Dirnhofer S; Zimpfer A; Went P
Ther Umsch; 2006 Apr; 63(4):273-8. PubMed ID: 16689459
[TBL] [Abstract][Full Text] [Related]
16. High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells.
Šimečková Š; Kahounová Z; Fedr R; Remšík J; Slabáková E; Suchánková T; Procházková J; Bouchal J; Kharaishvili G; Král M; Beneš P; Souček K
Sci Rep; 2019 Apr; 9(1):5695. PubMed ID: 30952903
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.
Iannelli F; Roca MS; Lombardi R; Ciardiello C; Grumetti L; De Rienzo S; Moccia T; Vitagliano C; Sorice A; Costantini S; Milone MR; Pucci B; Leone A; Di Gennaro E; Mancini R; Ciliberto G; Bruzzese F; Budillon A
J Exp Clin Cancer Res; 2020 Oct; 39(1):213. PubMed ID: 33032653
[TBL] [Abstract][Full Text] [Related]
18. A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer.
Rojas A; Zhang P; Wang Y; Foo WC; Muñoz NM; Xiao L; Wang J; Gores GJ; Hung MC; Blechacz B
Neoplasia; 2016 Jun; 18(6):371-86. PubMed ID: 27292026
[TBL] [Abstract][Full Text] [Related]
19. The Kit-activating mutation D816V enhances stem cell factor--dependent chemotaxis.
Taylor ML; Dastych J; Sehgal D; Sundstrom M; Nilsson G; Akin C; Mage RG; Metcalfe DD
Blood; 2001 Aug; 98(4):1195-9. PubMed ID: 11493470
[TBL] [Abstract][Full Text] [Related]
20. Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity.
Vummidi Giridhar P; Williams K; VonHandorf AP; Deford PL; Kasper S
Cancer Res; 2019 Mar; 79(6):1124-1137. PubMed ID: 30626627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]